Obinutuzumab 25 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 25 mg/mL
Reference Brands: Gazyva (USA), Gazyvaro (EU/UK)
Category: Oncology Cancer Care
Obinutuzumab is a humanized, glycoengineered monoclonal antibody targeting the CD20 antigen on B-cells. It is used alongside chemotherapy for conditions such as chronic lymphocytic leukaemia (CLL) and follicular lymphoma (FL) to enhance B-cell destruction via immune mediated mechanisms.
Obinutuzumab — third party manufacturing & bulk supply
Obinutuzumab 25 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Obinutuzumab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Obinutuzumab →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Obinutuzumab is used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and follicular lymphoma. It works by targeting the CD20 protein found on the surface of B-lymphocytes, helping the immune system destroy these cancerous cells.
Obinutuzumab is a humanized monoclonal antibody produced using recombinant DNA technology in Chinese hamster ovary (CHO) cells. It specifically binds to the CD20 antigen on B-cells, leading to their destruction.
The trade name of Obinutuzumab is Gazyva in the United States and Gazyvaro in the European Union and the United Kingdom.
Obinutuzumab (Gazyva/Gazyvaro) is developed and manufactured by Genentech, a member of the Roche Group.
The generic name is Obinutuzumab.
The brand names are Gazyva and Gazyvaro.
Obinutuzumab is manufactured by Roche and Genentech at facilities in Switzerland, Germany, and the United States under stringent biologic production standards.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
